CN106999523A - 黄金奇异果组合物及其制备和使用方法 - Google Patents

黄金奇异果组合物及其制备和使用方法 Download PDF

Info

Publication number
CN106999523A
CN106999523A CN201580064171.3A CN201580064171A CN106999523A CN 106999523 A CN106999523 A CN 106999523A CN 201580064171 A CN201580064171 A CN 201580064171A CN 106999523 A CN106999523 A CN 106999523A
Authority
CN
China
Prior art keywords
composition
powder
kiwifruit
gold
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580064171.3A
Other languages
English (en)
Chinese (zh)
Inventor
朱丽叶·安塞尔
保罗·布拉奇福特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anagenix Ip Ltd
Original Assignee
Anagenix Ip Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anagenix Ip Ltd filed Critical Anagenix Ip Ltd
Priority to CN202310308827.8A priority Critical patent/CN116270773A/zh
Priority to CN202310572047.4A priority patent/CN116763830A/zh
Publication of CN106999523A publication Critical patent/CN106999523A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/01—Instant products; Powders; Flakes; Granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CN201580064171.3A 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法 Pending CN106999523A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202310308827.8A CN116270773A (zh) 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法
CN202310572047.4A CN116763830A (zh) 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NZ702454 2014-11-28
NZ70245414 2014-11-28
NZ706405 2015-03-27
NZ70640515 2015-03-27
PCT/NZ2015/050200 WO2016085356A1 (en) 2014-11-28 2015-11-27 Gold kiwifruit compositions and methods of preparation and use therefor

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN202310308827.8A Division CN116270773A (zh) 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法
CN202310572047.4A Division CN116763830A (zh) 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法

Publications (1)

Publication Number Publication Date
CN106999523A true CN106999523A (zh) 2017-08-01

Family

ID=56074755

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202310308827.8A Pending CN116270773A (zh) 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法
CN202310572047.4A Pending CN116763830A (zh) 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法
CN201580064171.3A Pending CN106999523A (zh) 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CN202310308827.8A Pending CN116270773A (zh) 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法
CN202310572047.4A Pending CN116763830A (zh) 2014-11-28 2015-11-27 黄金奇异果组合物及其制备和使用方法

Country Status (16)

Country Link
US (4) US10512663B2 (enExample)
EP (2) EP4548775A3 (enExample)
JP (3) JP7330667B2 (enExample)
KR (2) KR20230156436A (enExample)
CN (3) CN116270773A (enExample)
BR (1) BR112017011078B1 (enExample)
CA (2) CA2967263A1 (enExample)
DK (1) DK3223838T3 (enExample)
ES (1) ES3023661T3 (enExample)
FI (1) FI3223838T3 (enExample)
MY (1) MY188290A (enExample)
NZ (1) NZ732197A (enExample)
PL (1) PL3223838T3 (enExample)
PT (1) PT3223838T (enExample)
SI (1) SI3223838T1 (enExample)
WO (1) WO2016085356A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111406116A (zh) * 2017-10-18 2020-07-10 Md保健株式会社 通过细菌宏基因组分析来诊断头颈癌的方法
CN111417732A (zh) * 2017-10-13 2020-07-14 Md保健株式会社 通过细菌宏基因组分析来诊断阿尔茨海默氏症的方法
CN111630189A (zh) * 2018-01-23 2020-09-04 Md保健株式会社 通过细菌性宏基因组分析来诊断胆管癌的方法
CN111727263A (zh) * 2018-02-14 2020-09-29 Md保健株式会社 通过细菌性宏基因组分析来诊断中风的方法

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3223838T3 (pl) * 2014-11-28 2025-05-26 Anagenix Ip Limited Kompozycje i sposoby przygotowywania i stosowania żółtego kiwi
KR101833348B1 (ko) * 2016-12-26 2018-03-02 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 유방암 진단방법
KR101833503B1 (ko) * 2016-12-26 2018-03-05 주식회사 엠디헬스케어 만성폐쇄성폐질환자에서 세균 메타게놈 분석을 통한 폐암 진단방법
KR101942197B1 (ko) * 2016-12-28 2019-01-24 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 전립선질환 진단 방법
KR101940426B1 (ko) * 2016-12-28 2019-01-18 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 대장종양 진단 방법
US11413318B2 (en) * 2017-06-06 2022-08-16 Sami-Sabinsa Group Limited Compositions and methods for management of atrophic gastritis and colitis
WO2019075273A1 (en) * 2017-10-11 2019-04-18 Gu Jennifer L INTESTINAL HEALTH COMPOSITIONS
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
CN109288104B (zh) * 2018-11-12 2023-09-01 方家铺子（莆田）绿色食品有限公司 一种桂圆鲜果挂黄处理设备及其处理方法
US11622974B2 (en) 2019-01-18 2023-04-11 C.P. Kelco U.S., Inc. Prebiotic composition and its use
CN110279814A (zh) * 2019-06-10 2019-09-27 湖北虹玮农业有限公司 一种用于中老年慢性便秘的功能食品
US11684645B2 (en) * 2019-11-26 2023-06-27 Tci Co., Ltd. Actinidia chinensis Planch ferment and use thereof
WO2022115709A2 (en) * 2020-11-30 2022-06-02 January, Inc. Methods and composition for treating metabolic syndrome
US20220233151A1 (en) * 2021-01-22 2022-07-28 Ethicon Llc Bariatric surgery post-surgical monitoring
KR102543549B1 (ko) * 2021-01-26 2023-06-15 주식회사 다솔마임마케팅사업부 칼라만시 발포정 및 그 제조 방법
CN113521109A (zh) * 2021-06-28 2021-10-22 广州知易生物科技有限公司 解纤维素拟杆菌在预防和/或治疗炎症性肠病中的应用
US12343366B2 (en) * 2021-11-05 2025-07-01 Tci Co., Ltd. Prebiotic composition and method for improving intestinal health using the same
CN116076711A (zh) * 2021-11-05 2023-05-09 百岳特生物技术（上海）有限公司 益生质组合物及其用途
CA3238788A1 (en) 2021-11-22 2023-05-25 Eric Michael Schott Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
JP7701899B2 (ja) * 2022-09-14 2025-07-02 花王株式会社 クロロゲン酸類吸収量の予測方法
KR102536627B1 (ko) * 2022-09-30 2023-05-30 (주)바이텍 키위 발효물을 포함하는 알코올성 간손상 예방 또는 개선용 조성물
US20250195594A1 (en) * 2023-12-18 2025-06-19 First Day Life Inc. Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics
US20250195588A1 (en) * 2023-12-18 2025-06-19 First Day Life, Inc. Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics
NL2038369B1 (en) * 2024-07-31 2025-03-06 Sunbird Company Ltd A composition of natural kiwifruit powder and postbiotics and its use in constipation improvement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US22355A (en) 1858-12-21 sherwood
JP2750767B2 (ja) * 1990-02-21 1998-05-13 雪印乳業株式会社 新規糖アルコール
NZ235972A (en) 1990-11-06 1995-04-27 Amaranathan Balasingham Fruit product by soft pulping after skin removal
CN1107308A (zh) * 1994-02-25 1995-08-30 中国癌症研究基金会 猕猴桃天然营养口服液
JPH10313822A (ja) 1997-05-20 1998-12-02 Pola Chem Ind Inc 腸内細菌叢改善剤及びそれを含有する組成物
AT503521A1 (de) 2006-05-05 2007-11-15 Omnica Gmbh Verwendung eines extraktes von kiwi-frucht
NZ554991A (en) * 2007-05-03 2009-11-27 Vital Food Processors Ltd Powdered kiwifruit extract compositions for the treatment of digestive dysfunction and/or gastrointestinal tract disorders
USPP22355P3 (en) * 2009-06-30 2011-12-20 Zespri Group Limited Kiwifruit plant named ‘ZESY002’
WO2011092261A1 (en) * 2010-01-28 2011-08-04 Ab-Biotics S.A. Probiotic composition for use in the treatment of bowel inflammation
PL3223838T3 (pl) * 2014-11-28 2025-05-26 Anagenix Ip Limited Kompozycje i sposoby przygotowywania i stosowania żółtego kiwi

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111417732A (zh) * 2017-10-13 2020-07-14 Md保健株式会社 通过细菌宏基因组分析来诊断阿尔茨海默氏症的方法
CN111417732B (zh) * 2017-10-13 2023-09-22 Md保健株式会社 通过细菌宏基因组分析来诊断阿尔茨海默氏症的方法
CN111406116A (zh) * 2017-10-18 2020-07-10 Md保健株式会社 通过细菌宏基因组分析来诊断头颈癌的方法
CN111630189A (zh) * 2018-01-23 2020-09-04 Md保健株式会社 通过细菌性宏基因组分析来诊断胆管癌的方法
CN111630189B (zh) * 2018-01-23 2023-09-22 Md保健株式会社 通过细菌性宏基因组分析来诊断胆管癌的方法
US11827939B2 (en) 2018-01-23 2023-11-28 Md Healthcare Inc. Method for diagnosing cholangiocarcinoma via bacterial metagenomic analysis
CN111727263A (zh) * 2018-02-14 2020-09-29 Md保健株式会社 通过细菌性宏基因组分析来诊断中风的方法
CN111727263B (zh) * 2018-02-14 2023-11-28 Md保健株式会社 通过细菌性宏基因组分析来诊断中风的方法

Also Published As

Publication number Publication date
US20170326190A1 (en) 2017-11-16
DK3223838T3 (da) 2025-04-28
NZ769769A (en) 2024-07-26
MY188290A (en) 2021-11-25
KR102599549B1 (ko) 2023-11-06
US20240091291A1 (en) 2024-03-21
WO2016085356A1 (en) 2016-06-02
KR20170088970A (ko) 2017-08-02
US10512663B2 (en) 2019-12-24
CN116763830A (zh) 2023-09-19
BR112017011078A2 (pt) 2017-12-26
JP2024088715A (ja) 2024-07-02
KR20230156436A (ko) 2023-11-14
US11642386B2 (en) 2023-05-09
EP4548775A2 (en) 2025-05-07
US20220105145A1 (en) 2022-04-07
CA3200468A1 (en) 2016-06-02
US20200197460A1 (en) 2020-06-25
JP7330667B2 (ja) 2023-08-22
CN116270773A (zh) 2023-06-23
PL3223838T3 (pl) 2025-05-26
US11090348B2 (en) 2021-08-17
EP3223838A1 (en) 2017-10-04
EP3223838B1 (en) 2025-02-05
EP4548775A3 (en) 2025-08-27
SI3223838T1 (sl) 2025-07-31
EP3223838A4 (en) 2018-08-01
CA2967263A1 (en) 2016-06-02
JP7471668B2 (ja) 2024-04-22
PT3223838T (pt) 2025-04-28
JP2017537156A (ja) 2017-12-14
FI3223838T8 (fi) 2025-06-16
FI3223838T3 (fi) 2025-05-05
JP2022078050A (ja) 2022-05-24
NZ732197A (en) 2022-07-01
ES3023661T3 (en) 2025-06-02
BR112017011078B1 (pt) 2021-05-11

Similar Documents

Publication Publication Date Title
US11642386B2 (en) Gold kiwifruit compositions and methods of preparation and use therefor
US12370226B2 (en) Prevotella copri compositions
Xiao et al. Lactic acid bacteria in health and disease
JP7360420B2 (ja) ディスバイオシスの治療のために用いられるブドウ果皮
KR20210005717A (ko) 프로바이오틱 비피도박테리움 브레베 균주 및 상기 균주를 포함하는 조성물
Stover et al. Pre-and probiotic supplementation in ruminant livestock production
CA3223260A1 (en) Probiotic composition for the treatment of increased intestinal permeability
EP2220210B1 (en) Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect
KR20240099205A (ko) 장내 미생물군집 조절을 위한 프로바이오틱 조성물
SP Effects of Resveratrol in a Mouse Model of Alcohol Addiction
Braun Comparison of Bacterial Phylogenetic Diversity in Rat Fecal Pellets and Cecum & Probiotic and Blueberry Treatment Effects on Bacterial Community Composition
HK40065763A (zh) 产生短链脂肪酸的益生菌菌株和包含该益生菌菌株的组合物
Pascal Gut microbiome and Metabolic Syndrome

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170801

RJ01 Rejection of invention patent application after publication